With a foundation in science and an entrepreneurial mindset, she combines strategic insight, integrity, and resilience to help organisations and individuals thrive.
Sue’s 20+ years of experience in consulting, corporate leadership, and entrepreneurship, has seen her found, grow and sell three successful global businesses and invest in many others. She is a visionary leader who sees the potential in others she mentors.
Sue is a dynamic, results-driven leader with a talent for solving complex challenges, removing barriers to growth, and driving transformational change.
Susan Lohr
Entrepreneurial I Pragmatic I Impactful
She specialises in identifying roadblocks, unlocking potential, and creating clear, actionable pathways to success. Grounded in behavioural science, her approach goes beyond theory—she delivers practical, scalable solutions that foster resilience, innovation, and long-term impact. Whether guiding executives, strengthening teams, or implementing large-scale organisational strategies, Sue is a catalyst for growth and change.
Sue’s core strengths
Problem-Solving & Growth Acceleration
Identifying obstacles, cutting through complexity, and unlocking new opportunities.
Entrepreneurial Leadership
Building and scaling businesses with a results-driven approach.
Behavioural Science Expertise
Applying scientific insights to drive organisational performance.
Team Coaching and Capability Building
Creating high-performance environments and resilient teams.
Integrity and Grit
Leading with authenticity and a focus on impactful outcomes.
Experience & Achievements
🟠 Partner in The Vibrant Company, pioneering a science-driven approach to leadership and organisational growth.
🟠 Partner and Chairman of fast-growing capability consultancy. Led sale in July 2020, and delivered exceptional growth through earn out.
🟠 Active angel investor through Philadelphia-based investment group, leading due diligence and support to CEOs.
🟠 Co-founder of product-based pet company, raising $0.25M via crowdfunding to launch 1st product. Led subsequent investment round and sale of assets in 2017.
🟠 Co-founder of US-based sector-leading medical communications consultancy and led sale to public company in 2011.
🟠 Commercial Director for global pharmaceutical company franchise worth >$3.5BN.